What is Hunan Er-Kang Pharmaceutical Co Median PS Value?
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Hunan Er-Kang Pharmaceutical Co's Median PS Value or its related term are showing as below:
SZSE:300267'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.6 Med: 0.75 Max: 0.89
Current: 0.85
During the past 13 years, the highest Price to Median PS Value of Hunan Er-Kang Pharmaceutical Co was 0.89. The lowest was 0.60. And the median was 0.75.
SZSE:300267's Price-to-Median-PS-Value is ranked better than 51.48% of 507
companies
in the Drug Manufacturers industry
Industry Median: 0.85
vs SZSE:300267: 0.85
Hunan Er-Kang Pharmaceutical Co Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Hunan Er-Kang Pharmaceutical Co Median PS Value Chart
Competitive Comparison of Hunan Er-Kang Pharmaceutical Co's Median PS Value
For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Er-Kang Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hunan Er-Kang Pharmaceutical Co's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hunan Er-Kang Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Hunan Er-Kang Pharmaceutical Co's Price-to-Median-PS-Value falls into.
Hunan Er-Kang Pharmaceutical Co Median PS Value Calculation
10-Year Median PS Ratio is 4.1281.
Hunan Er-Kang Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.734.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Hunan Er-Kang Pharmaceutical Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.59
/
3.03
=
0.85
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hunan Er-Kang Pharmaceutical Co Median PS Value Related Terms
Thank you for viewing the detailed overview of Hunan Er-Kang Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Business Description
Hunan Er-Kang Pharmaceutical Co Ltd develops, produces and sells pharmaceutical products in China. The company's main products include pharmaceutical excipients and antibiotics. It offers pharmaceutical excipients, APIs and finished drug products. The pharmaceutical excipients include products such as glycerol, ethanol pharmaceutically, acceptable propylene glycol, sodium hydroxide, and pharmaceutically acceptable sugar. The company's finished drugs primarily include sulbenicillin sodium for injection and compound liquorice tablets. Its APIs include glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. Geographically, all the activities are carried out through China.
Hunan Er-Kang Pharmaceutical Co (SZSE:300267) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300267 has been successfully added to your 